$INUV
Inuvo, Inc. Stock $inuv

$inuv Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000082932322000015 Filed on March 17, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$19.74M	$59.83M	$12.90M
YoY Change	52.96%	34.03%	-29.2%
Cost Of Revenue	$8.460M	$15.93M	$2.142M
YoY Change	295.03%	91.96%	-60.27%
Gross Profit	$11.28M	$43.90M	$10.76M
YoY Change	4.79%	20.81%	-16.14%
Gross Profit Margin	57.14%	73.38%	83.4%
Selling, General & Admin	$12.31M	$7.198M	$12.61M
YoY Change	-2.37%	-5.67%	-10.88%
% of Gross Profit	109.15%	16.4%	117.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$884.6K	$3.143M	$861.9K
YoY Change	2.64%	-2.93%	-8.91%
% of Gross Profit	7.84%	7.16%	8.01%
Operating Expenses	$12.31M	$51.68M	$12.61M
YoY Change	-2.37%	16.41%	-10.88%
Operating Profit	-$1.032M	-$7.771M	-$1.847M
YoY Change	-44.11%	-3.45%	40.5%
Interest Expense	-$50.34K	-$86.98K	-$2.170K
YoY Change	2219.82%	-65.69%	-107.39%
% of Operating Profit
Other Income/Expense, Net	-$158.5K	$257.0K	$1.134M
YoY Change	-113.98%	-74.24%	-66.57%
Pretax Income	-$1.241M	-$7.601M	-$715.0K
YoY Change	73.57%	4.05%	-40.07%
Income Tax
% Of Pretax Income
Net Earnings	-$1.241M	-$7.601M	-$715.0K
YoY Change	73.57%	4.05%	-16.73%
Net Earnings / Revenue	-6.29%	-12.7%	-5.54%
Basic Earnings Per Share		-$0.06
Diluted Earnings Per Share	-$10.45K	-$0.06	-$7.300K
COMMON SHARES
Basic Shares Outstanding	118.7M shares	117.6M shares	97.62M shares
Diluted Shares Outstanding		117.6M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.40M	$12.40M	$7.891M
YoY Change	57.2%	57.2%	2015.52%
Cash & Equivalents	$10.48M		$7.891M
Short-Term Investments	$1.928M	$1.928M
Other Short-Term Assets	$1.408M	$1.408M	$413.4K
YoY Change	240.6%	240.6%	73.66%
Inventory
Prepaid Expenses	$1.408M		$413.4K
Receivables	$9.266M	$9.266M	$6.228M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$23.08M	$23.08M	$14.53M
YoY Change	58.81%	58.81%	78.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.507M	$2.350M	$1.187M
YoY Change	26.93%	7.33%	-13.62%
Goodwill	$9.853M		$9.853M
YoY Change	0.0%		0.0%
Intangibles	$6.721M		$8.586M
YoY Change	-21.73%		-17.85%
Long-Term Investments	$859.5K	$859.5K
YoY Change
Other Assets	$35.72K	$1.136M	$20.89K
YoY Change	71.02%	5336.67%	0.0%
Total Long-Term Assets	$20.92M	$20.92M	$20.65M
YoY Change	1.3%	1.3%	-8.4%
TOTAL ASSETS
Total Short-Term Assets	$23.08M	$23.08M	$14.53M
Total Long-Term Assets	$20.92M	$20.92M	$20.65M
Total Assets	$44.00M	$44.00M	$35.18M
YoY Change	25.06%	25.06%	14.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.845M	$4.845M	$4.048M
YoY Change	19.67%	19.67%	-46.17%
Accrued Expenses	$5.374M	$5.697M	$4.216M
YoY Change	27.46%	28.72%	16.66%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$103.0K	$103.0K	$246.8K
YoY Change	-58.28%	-58.28%	-60.04%
Total Short-Term Liabilities	$10.66M	$10.66M	$8.729M
YoY Change	22.15%	22.15%	-44.32%
LONG-TERM LIABILITIES
Long-Term Debt	$105.4K	$105.4K	$243.3K
YoY Change	-56.68%	-56.68%
Other Long-Term Liabilities	$13.30K	$314.1K	$574.0K
YoY Change	-97.68%	-61.36%	904.09%
Total Long-Term Liabilities	$526.5K	$419.5K	$1.163M
YoY Change	-54.74%	-60.28%	108.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.66M	$10.66M	$8.729M
Total Long-Term Liabilities	$526.5K	$419.5K	$1.163M
Total Liabilities	$11.19M	$11.19M	$9.892M
YoY Change	13.11%	13.11%	-39.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$144.0M		-$136.4M
YoY Change	5.57%		5.66%
Common Stock	$118.7K		$98.04K
YoY Change	21.13%		87.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$0.00
YoY Change			-100.0%
Treasury Stock Shares			0.000 shares
Shareholders Equity	$32.81M	$32.81M	$25.29M
YoY Change
Total Liabilities & Shareholders Equity	$44.00M	$44.00M	$35.18M
YoY Change	25.06%	25.06%	14.63%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$1.241M	-$7.601M	-$715.0K
YoY Change	73.57%	4.05%	-16.73%
Depreciation, Depletion And Amortization	$884.6K	$3.143M	$861.9K
YoY Change	2.64%	-2.93%	-8.91%
Cash From Operating Activities	$2.267M	-$5.276M	-$1.264M
YoY Change	-279.39%	-5.77%	81.6%
INVESTING ACTIVITIES
Capital Expenditures	-$417.3K	-$1.597M	-$332.9K
YoY Change	25.33%	34.76%	10.58%
Acquisitions
YoY Change
Other Investing Activities	-$3.001M	-$3.001M
YoY Change
Cash From Investing Activities	-$3.418M	-$4.598M	-$332.9K
YoY Change	926.61%	287.9%	10.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$13.14M
YoY Change		-20.05%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-75.68K	$12.46M	-40.93K
YoY Change	84.9%	-12.89%	-106.24%
NET CHANGE
Cash From Operating Activities	2.267M	-$5.276M	-1.264M
Cash From Investing Activities	-3.418M	-$4.598M	-332.9K
Cash From Financing Activities	-75.68K	$12.46M	-40.93K
Net Change In Cash	-1.226M	$2.585M	-1.638M
YoY Change	-25.1%	-65.61%	380.12%
FREE CASH FLOW
Cash From Operating Activities	$2.267M	-$5.276M	-$1.264M
Capital Expenditures	-$417.3K	-$1.597M	-$332.9K
Free Cash Flow	$2.684M	-$3.679M	-$930.8K
YoY Change	-388.38%	-16.65%	135.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000829323
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-32442
CY2021	dei	Entity Registrant Name EntityRegistrantName	INUVO, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0450450
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 President Clinton Ave.
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Little Rock
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	AR
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	72201
CY2021	dei	City Area Code CityAreaCode	501
CY2021	dei	Local Phone Number LocalPhoneNumber	205-8508
CY2021	dei	Security12b Title Security12bTitle	Common Stock
CY2021	dei	Trading Symbol TradingSymbol	INUV
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	104600000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	119547810	shares
CY2021	inuv	Intellectual Property Numberof Issued Patents IntellectualPropertyNumberofIssuedPatents	17	patent
CY2021	dei	Auditor Firm AuditorFirmId	274
CY2020	dei	Auditor Firm AuditorFirmId	199
CY2021	dei	Auditor Name AuditorName	EisnerAmper, LLP
CY2021	dei	Auditor Location AuditorLocation	Iselin, NJ
CY2020	dei	Auditor Name AuditorName	Mayer Hoffman McCann P.C.
CY2020	dei	Auditor Location AuditorLocation	Clearwater, Florida
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10475964	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4048260	USD
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1927979	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7890665	USD
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	202904	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	209667	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9265813	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6227610	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1408186	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	413435	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	23077942	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	14531710	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1506766	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1187061	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	641306	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	606573	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	201902	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	395910	USD
CY2021Q4	inuv	Referral Agreement ReferralAgreement	1100000	USD
CY2020Q4	inuv	Referral Agreement ReferralAgreement	0	USD
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	859512	USD
CY2020Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6720585	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8586089	USD
CY2021Q4	us-gaap	Goodwill Goodwill	9853342	USD
CY2020Q4	us-gaap	Goodwill Goodwill	9853342	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35720	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	20886	USD
CY2021Q4	inuv	Other Assets Total Noncurrent OtherAssetsTotalNoncurrent	19412366	USD
CY2020Q4	inuv	Other Assets Total Noncurrent OtherAssetsTotalNoncurrent	19462800	USD
CY2021Q4	us-gaap	Assets Assets	43997074	USD
CY2020Q4	us-gaap	Assets Assets	35181571	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4844716	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5374391	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4216448	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	340478	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	217671	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	102954	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	246793	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10662539	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8729172	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	107000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	107000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	300827	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	388902	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	105411	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	93426	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13302	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	573957	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	526540	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1163285	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	118747447	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	98035829	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	118748	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	98036	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	176586529	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	161541448	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	53737	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-143951019	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-136350370	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	32807995	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	25289114	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43997074	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35181571	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	59830688	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	44640007	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	15925837	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	8296483	USD
CY2021	us-gaap	Gross Profit GrossProfit	43904851	USD
CY2020	us-gaap	Gross Profit GrossProfit	36343524	USD
CY2021	us-gaap	Marketing Expense MarketingExpense	33096000	USD
CY2020	us-gaap	Marketing Expense MarketingExpense	27410284	USD
CY2021	us-gaap	Salaries And Wages SalariesAndWages	11381279	USD
CY2020	us-gaap	Salaries And Wages SalariesAndWages	9350831	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7198213	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7630990	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	51675492	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	44392105	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-7770641	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-8048581	USD
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-86983	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-253505	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	256975	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	997517	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-7600649	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-7304569	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	53737	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7546912	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7304569	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	117613845	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77473479	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	117613845	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77473479	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	14453550	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-7304569	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	858683	USD
CY2020	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	0	USD
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16432190	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	74550	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	923810	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	25289114	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-7600649	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	53737	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2179254	USD
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	272049	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1569	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13137500	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	19519	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	32807995	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-7600649	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-7304569	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3143168	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3237930	USD
CY2021	inuv	Finance And Operating Lease Right Of Use Asset Amortization FinanceAndOperatingLeaseRightOfUseAssetAmortization	322746	USD
CY2020	inuv	Finance And Operating Lease Right Of Use Asset Amortization FinanceAndOperatingLeaseRightOfUseAssetAmortization	367981	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2179254	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	858683	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	-266762	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	12500	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	11092	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7487	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	135000	USD
CY2021	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress	420000	USD
CY2020	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress	0	USD
CY2021	inuv	Derecognition Of Contingencies DerecognitionOfContingencies	110000	USD
CY2020	inuv	Derecognition Of Contingencies DerecognitionOfContingencies	0	USD
CY2021	inuv	Ppp Loan Forgiveness PPPLoanForgiveness	0	USD
CY2020	inuv	Ppp Loan Forgiveness PPPLoanForgiveness	1109000	USD
CY2021	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	USD
CY2020	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	1260978	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-65700	USD
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	0	USD
CY2020	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	102664	USD
CY2021	inuv	Amortization Of Interest Expense AmortizationOfInterestExpense	0	USD
CY2020	inuv	Amortization Of Interest Expense AmortizationOfInterestExpense	13167	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	18286	USD
CY2021	inuv	Payments For Third Party Rights Agreement PaymentsForThirdPartyRightsAgreement	0	USD
CY2020	inuv	Payments For Third Party Rights Agreement PaymentsForThirdPartyRightsAgreement	78762	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3045690	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1167175	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	1100000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	992978	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	175702	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	796456	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2271578	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1264687	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	623576	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5276257	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5599335	USD
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1597369	USD
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1185335	USD
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	3143000	USD
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	142484	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4597885	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1185335	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13137500	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	16432190	USD
CY2021	inuv	Proceeds From Paycheck Protection Program And Small Business Administration Loan ProceedsFromPaycheckProtectionProgramAndSmallBusinessAdministrationLoan	0	USD
CY2020	inuv	Proceeds From Paycheck Protection Program And Small Business Administration Loan ProceedsFromPaycheckProtectionProgramAndSmallBusinessAdministrationLoan	1258900	USD
CY2021	inuv	Proceeds From Other Commitment ProceedsFromOtherCommitment	0	USD
CY2020	inuv	Proceeds From Other Commitment ProceedsFromOtherCommitment	500000	USD
CY2021	inuv	Payments For Paycheck Protection Program And Small Business Administration Loan PaymentsForPaycheckProtectionProgramAndSmallBusinessAdministrationLoan	149900	USD
CY2020	inuv	Payments For Paycheck Protection Program And Small Business Administration Loan PaymentsForPaycheckProtectionProgramAndSmallBusinessAdministrationLoan	0	USD
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	USD
CY2020	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-3381364	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	257679	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	432830	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	272049	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	74550	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1569	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12459441	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14302346	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2585299	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7517676	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7890665	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	372989	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10475964	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7890665	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	55476	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	207213	USD
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	923810	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	125825	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	547303	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	344311	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	249595	USD
CY2021Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	13300000	USD
CY2021Q4	inuv	Working Capital Net WorkingCapitalNet	12400000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-144000000	USD
CY2020Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	1500000	USD
CY2020Q2	inuv	Paycheck Protection Program Loan PaycheckProtectionProgramLoan	1100000	USD
CY2020Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	5500000	USD
CY2020Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	10750000	USD
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	8000000	USD
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	6250000	USD
CY2021Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2000000	USD
CY2021Q1	inuv	Cash Deposited Interest Bearing CashDepositedInterestBearing	10000000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	59830688	USD
CY2021	inuv	Percentage Of Total Revenue PercentageOfTotalRevenue	1.000
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	44640007	USD
CY2020	inuv	Percentage Of Total Revenue PercentageOfTotalRevenue	1.000
CY2021	us-gaap	Depreciation Depreciation	1277664	USD
CY2020	us-gaap	Depreciation Depreciation	1372426	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2020	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2021	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2021Q4	inuv	Number Of Employees Employed Under Grant NumberOfEmployeesEmployedUnderGrant	41	employee
CY2021Q4	inuv	Number Of Employees Under Minimum Amount Required To Be Employed Under Grant NumberOfEmployeesUnderMinimumAmountRequiredToBeEmployedUnderGrant	2	employee
CY2021Q4	inuv	Number Of Employees Required To Be Employed Under Grant NumberOfEmployeesRequiredToBeEmployedUnderGrant	43	employee
CY2021Q4	inuv	Accrued Grant Current AccruedGrantCurrent	10000	USD
CY2020Q4	inuv	Number Of Employees Employed Under Grant NumberOfEmployeesEmployedUnderGrant	38	employee
CY2020Q4	inuv	Number Of Employees Under Minimum Amount Required To Be Employed Under Grant NumberOfEmployeesUnderMinimumAmountRequiredToBeEmployedUnderGrant	12	employee
CY2020Q4	inuv	Number Of Employees Required To Be Employed Under Grant NumberOfEmployeesRequiredToBeEmployedUnderGrant	50	employee
CY2020Q4	inuv	Accrued Grant Current AccruedGrantCurrent	60000	USD
CY2020Q3	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	376527	shares
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of credit risk - We are exposed to concentrations of risk primarily in cash and accounts receivable, which are generally not collateralized. Our policy is to place our cash with high credit, quality financial institutions in order to limit the amount of credit exposure. Our cash deposits exceed FDIC limits. We do not require collateral from our customers, but our credit extension and collection policies include monitoring payments and aggressively pursuing delinquent accounts. We maintain allowances for potential credit losses.
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of financial statements, in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"), requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, net revenues and expenses and disclosure of contingent assets and liabilities. The estimates and assumptions used in the accompanying consolidated financial statements are based upon management’s regular evaluation of the relevant facts and circumstances as of the date of the consolidated financial statements. We regularly evaluate estimates and assumptions related to goodwill and purchased intangible asset valuations and income tax valuation allowance. Actual results may differ from the estimates and assumptions used in preparing the accompanying consolidated financial statements, and such differences could be material.</span>
CY2021Q4	inuv	Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax EquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax	272000	USD
CY2021	inuv	Marketable Securities Gross Realized Gain MarketableSecuritiesGrossRealizedGain	5000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	209667	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	225000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7487	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	135000	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	16154	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	150333	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	1904	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	202904	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	209667	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14831528	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13242050	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13324762	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12054989	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1506766	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1187061	USD
CY2021	us-gaap	Depreciation Depreciation	1277664	USD
CY2020	us-gaap	Depreciation Depreciation	1372426	USD
CY2021Q4	inuv	Finite Livedand Indefinite Lived Intangible Assets Long Term Portion Gross FiniteLivedandIndefiniteLivedIntangibleAssetsLongTermPortionGross	17565000	USD
CY2021Q4	inuv	Finite Lived Intangible Assets Long Term Portion Accumulated Amortization FiniteLivedIntangibleAssetsLongTermPortionAccumulatedAmortization	10844415	USD
CY2021Q4	inuv	Intangible Assets Long Term Portion Net Of Accumulated Amortization IntangibleAssetsLongTermPortionNetOfAccumulatedAmortization	6720585	USD
CY2021	inuv	Amortization Of Intangible Assets Relating To Long Term Assets AmortizationOfIntangibleAssetsRelatingToLongTermAssets	1865504	USD
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	9853342	USD
CY2021Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
CY2021Q4	us-gaap	Goodwill Goodwill	9853342	USD
CY2020Q4	inuv	Finite Livedand Indefinite Lived Intangible Assets Long Term Portion Gross FiniteLivedandIndefiniteLivedIntangibleAssetsLongTermPortionGross	17565000	USD
CY2020Q4	inuv	Finite Lived Intangible Assets Long Term Portion Accumulated Amortization FiniteLivedIntangibleAssetsLongTermPortionAccumulatedAmortization	8978911	USD
CY2020Q4	inuv	Intangible Assets Long Term Portion Net Of Accumulated Amortization IntangibleAssetsLongTermPortionNetOfAccumulatedAmortization	8586089	USD
CY2020	inuv	Amortization Of Intangible Assets Relating To Long Term Assets AmortizationOfIntangibleAssetsRelatingToLongTermAssets	1865504	USD
CY2020Q4	us-gaap	Goodwill Gross GoodwillGross	9853342	USD
CY2020Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
CY2021Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	0	USD
CY2020Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	50000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	9853342	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1071294	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	984500	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	769917	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	469500	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	469500	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2565875	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6330586	USD
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	4267980	USD
CY2020Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	3234192	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	956998	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	440578	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	121533	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	423373	USD
CY2021Q4	inuv	Accrued Grant Current AccruedGrantCurrent	10000	USD
CY2020Q4	inuv	Accrued Grant Current AccruedGrantCurrent	60000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	17880	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	8305	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5374391	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4216448	USD
CY2021Q4	inuv	Lease Liability Deferred Rent Noncurrent LeaseLiabilityDeferredRentNoncurrent	13302	USD
CY2020Q4	inuv	Lease Liability Deferred Rent Noncurrent LeaseLiabilityDeferredRentNoncurrent	4057	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	420000	USD
CY2021Q4	inuv	Sba Loan Liability Noncurrent SBALoanLiabilityNoncurrent	0	USD
CY2020Q4	inuv	Sba Loan Liability Noncurrent SBALoanLiabilityNoncurrent	149900	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13302	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	573957	USD
CY2020Q2	inuv	Paycheck Protection Program Loan PaycheckProtectionProgramLoan	1100000	USD
CY2021	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	0	USD
CY2020Q2	inuv	Sba Loan Liability Noncurrent SBALoanLiabilityNoncurrent	149900	USD
CY2021Q3	inuv	Referral Agreement ReferralAgreement	1500000	USD
CY2021Q3	inuv	Referral Agreement Term ReferralAgreementTerm	P5Y
CY2021	inuv	Amortization Of Referral Agreement As Marketing Expense AmortizationOfReferralAgreementAsMarketingExpense	100000	USD
CY2021Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	300000	shares
CY2021Q3	inuv	Class Of Warrant Or Right Vesting Period ClassOfWarrantOrRightVestingPeriod	P2Y
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	0	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.02
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2021	inuv	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	0.02
CY2020	inuv	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	0.03
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.25
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.25
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	33727960	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	36484500	USD
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	585500	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	447700	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	239800	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	211600	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	3800	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	18000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	56900	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	58800	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	610900	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	351500	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	472500	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	35576360	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	37693100	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	33988760	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35848400	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1587600	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1844700	USD
CY2021Q4	inuv	Deferred Tax Liabilities Intangible Assetsand Property Plantand Equipment DeferredTaxLiabilitiesIntangibleAssetsandPropertyPlantandEquipment	1373300	USD
CY2020Q4	inuv	Deferred Tax Liabilities Intangible Assetsand Property Plantand Equipment DeferredTaxLiabilitiesIntangibleAssetsandPropertyPlantandEquipment	1449900	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	321300	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	501800	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1694600	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1951700	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	107000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	107000	USD
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	99454160	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	23100000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	107000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2179254	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	858683	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3595258	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3960001	shares
CY2021Q4	inuv	Options And Rsas Exercised OptionsAndRsasExercised	7745649	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2705861	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	14413011	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1500	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.56
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9500	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.56
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4750	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.56
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3250	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.56
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.56
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.56
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3931428	shares
CY2020Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	688000	USD
CY2020Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3115001	shares
CY2020Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	545125	USD
CY2020Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1400285	shares
CY2020Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	245050	USD
CY2020Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	5500000	USD
CY2020Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	10750000	USD
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	8000000	USD
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	6250000	USD
CY2021Q3	inuv	Class Of Warrant Or Right Granted In Period ClassOfWarrantOrRightGrantedInPeriod	300000	shares
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	149551	USD
CY2021Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P7Y
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	20000	USD
CY2021	inuv	Fair Value Adjustment Of Warrants Unrealized FairValueAdjustmentOfWarrantsUnrealized	130000	USD
CY2020Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	376527	shares
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.04
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	260540	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	186483	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	641306	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	201902	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	606573	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	395910	USD
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	322747	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	367981	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	532585	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y5M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0625
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	114865	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	84127	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	208365	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	31021	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	230013	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	21648	USD
CY2021	inuv	Finance Lease Payments FinanceLeasePayments	248035	USD
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0625
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	380482	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	297921	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	13128	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	2143	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	1072	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	694746	USD
CY2021Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	53441	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	641305	USD
CY2020Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3931428	shares
CY2020Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.175
CY2020Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	688000	USD

Files In Submission

Name	View Source	Status
0000829323-22-000015-index-headers.html	Edgar Link	pending
0000829323-22-000015-index.html	Edgar Link	pending
0000829323-22-000015.txt	Edgar Link	pending
0000829323-22-000015-xbrl.zip	Edgar Link	pending
a1021-argrantamendment.htm	Edgar Link	pending
a231-inuvo10kconsent2021.htm	Edgar Link	pending
ex311-q4.htm	Edgar Link	pending
ex312-q4.htm	Edgar Link	pending
ex321-q4.htm	Edgar Link	pending
ex322-q4.htm	Edgar Link	pending
exhibit232.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
inuv-20211231.htm	Edgar Link	pending
inuv-20211231.xsd	Edgar Link	pending
inuv-20211231_cal.xml	Edgar Link	unprocessable
inuv-20211231_def.xml	Edgar Link	unprocessable
inuv-20211231_g1.jpg	Edgar Link	pending
inuv-20211231_htm.xml	Edgar Link	completed
inuv-20211231_lab.xml	Edgar Link	unprocessable
inuv-20211231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INUV
Inuvo, Inc. Stock $inuv

2021 Q4 Form 10-K Financial Statement

#000082932322000015 Filed on March 17, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INUV Inuvo, Inc. Stock $inuv

2021 Q4 Form 10-K Financial Statement

#000082932322000015 Filed on March 17, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INUV
Inuvo, Inc. Stock $inuv